Moedas / MLYS
MLYS: Mineralys Therapeutics Inc
15.02
USD
0.82
(5.77%)
A taxa do MLYS para hoje mudou para 5.77%. Paralelamente, o preço mais baixo no mercado atingiu 14.07 e o mais alto foi 15.17.
Veja a dinâmica do par de moedas Mineralys Therapeutics Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
MLYS Notícias
- Investing Jefferies maintains Hold rating on Mineralys stock amid AstraZeneca data
- Investing Mineralys reports positive phase 3 results for hypertension drug
- Investing Mineralys stock holds Buy rating at H.C. Wainwright after CKD trial
- Benzinga Mineralys Therapeutics: Investigational Drug Shows Benefit In Hypertensive Patients With Chronic Kidney Disease, Stock Jumps - Mineralys Therapeutics (NASDAQ:MLYS)
- Investing Mineralys Therapeutics stock jumps after positive kidney disease trial data
- Investing Mineralys reports positive phase 2 data for lorundrostat in CKD
- Seeking Alpha PGIM Jennison Health Sciences Fund Q1 2025 Commentary (PHLAX)
- Benzinga This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Core Natural Resources (NYSE:CNR), Coinbase Global (NASDAQ:COIN)
- Investing Jefferies initiates Mineralys Therapeutics stock with hold rating
- Seeking Alpha Akebia Therapeutics (AKBA): Stock At Fair Value Amid Robust Drug Adoption Into 2026
- Seeking Alpha Mineralys Therapeutics: Merits A Small 'Speculative' Holding (NASDAQ:MLYS)
- Investing Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension
- Investing Mineralys to present lorundrostat trial data at ESH 2025
- Investing Mineralys at BofA Securities 2025: Lorundrostat’s Hypertension Promise
- TipRanks 3 Best Stocks to Buy Now, 4/1/2025, According to Top Analysts - TipRanks.com
- TipRanks 3 Best Stocks to Buy Now, 3/31/2025, According to Top Analysts - TipRanks.com
- Investing Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual
- Benzinga Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Lazard (NYSE:LAZ), Amylyx Pharmaceuticals (NASDAQ:AMLX)
- Seeking Alpha Mineralys: Prospects Just Got Better With Successful Pivotal Data Readouts (NASDAQ:MLYS)
- Benzinga Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate - Mineralys Therapeutics (NASDAQ:MLYS)
- Benzinga Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher - Checkpoint Therapeutics (NASDAQ:CKPT), Robinhood Markets (NASDAQ:HOOD)
- Benzinga Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday - The Campbell's (NASDAQ:CPB), Archer-Daniels Midland (NYSE:ADM)
- Investing Mineralys Therapeutics stock soars on positive hypertension trial results
- TipRanks 3 Best Stocks to Buy Now, 2/26/2025, According to Top Analysts - TipRanks.com
Faixa diária
14.07
15.17
Faixa anual
8.24
18.99
- Fechamento anterior
- 14.49
- Open
- 14.20
- Bid
- 15.02
- Ask
- 15.32
- Low
- 14.07
- High
- 15.17
- Volume
- 1.478 K
- Mudança diária
- 5.77%
- Mudança mensal
- 11.42%
- Mudança de 6 meses
- 45.83%
- Mudança anual
- 20.26%
15 julho, terça-feira
11:00
ALL
- Atu.
- Projeç.
- Prév.
12:30
USD
- Atu.
- Projeç.
- -0.3%
- Prév.
- 0.1%
12:30
USD
- Atu.
- Projeç.
- 0.2%
- Prév.
- 0.1%
12:30
USD
- Atu.
- Projeç.
- 2.4%
- Prév.
- 2.4%
12:30
USD
- Atu.
- Projeç.
- 2.7%
- Prév.
- 2.8%
12:30
USD
- Atu.
- Projeç.
- 321.516
- Prév.
- 321.465
12:30
USD
- Atu.
- Projeç.
- 327.606
- Prév.
- 326.854
12:30
USD
- Atu.
- Projeç.
- 0.1%
- Prév.
- 0.3%
12:30
USD
- Atu.
- Projeç.
- Prév.
- 0.2%
12:30
USD
- Atu.
- Projeç.
- Prév.
- 0.2%
12:30
USD
- Atu.
- Projeç.
- 320.395
- Prév.
- 320.580
12:30
USD
- Atu.
- Projeç.
- Prév.
- 327.509
12:30
USD
- Atu.
- Projeç.
- 2.2
- Prév.
- -16.0
13:15
USD
- Atu.
- Projeç.
- Prév.
15:00
USD
- Atu.
- Projeç.
- 0.2%
- Prév.
- 0.2%
16:45
USD
- Atu.
- Projeç.
- Prév.